The Enterprise Value as of December 2025 (TTM) for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is 2.56B

According to Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.56B. This represents a change of -12.24% compared to the average of 2.92B of the last 4 quarters.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Historical Enterprise Value (quarterly & annually)

How has 1762.TW Enterprise Value performed in the past?

The mean historical Enterprise Value of Chunghwa Chemical Synthesis & Biotech Co., Ltd. over the last ten years is 3.91B. The current 2.56B Enterprise Value has changed 6.46% with respect to the historical average. Over the past ten years (40 quarters), 1762.TW's Enterprise Value was at its highest in in the June 2023 quarter at 7.69B. The Enterprise Value was at its lowest in in the June 2025 quarter at 2.08B.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Average Enterprise Value

How has 1762.TW Enterprise Value performed in the past?

The current Enterprise Value of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Enterprise Value vs. Peers

How is 1762.TW’s Enterprise Value compared to its peers?

Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s Enterprise Value is greater than Advagene Biopharma Co., Ltd. (1.73B), greater than Genomics BioSci & Tech. Co.,Ltd. (2.21B), greater than Sunny Pharmtech Inc. (2.46B), greater than Greenyn Biotechnology Co., Ltd (2.09B), less than Meribank Biotech Co., Ltd (2.66B), greater than Hcmed (2.28B), greater than InnoPharmax Inc. (2.10B), greater than Shangya Technology Co., Ltd. (2.02B), greater than NaviFUS Corp. (1.30B), greater than GlycoNex Incorporation (2.21B),

Build a custom stock screener for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chunghwa Chemical Synthesis & Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chunghwa Chemical Synthesis & Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.